394 related articles for article (PubMed ID: 22723521)
1. Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.
Berthier CC; Bethunaickan R; Gonzalez-Rivera T; Nair V; Ramanujam M; Zhang W; Bottinger EP; Segerer S; Lindenmeyer M; Cohen CD; Davidson A; Kretzler M
J Immunol; 2012 Jul; 189(2):988-1001. PubMed ID: 22723521
[TBL] [Abstract][Full Text] [Related]
2. Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.
Bethunaickan R; Berthier CC; Zhang W; Kretzler M; Davidson A
PLoS One; 2013; 8(10):e77489. PubMed ID: 24167575
[TBL] [Abstract][Full Text] [Related]
3. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
Bethunaickan R; Berthier CC; Ramanujam M; Sahu R; Zhang W; Sun Y; Bottinger EP; Ivashkiv L; Kretzler M; Davidson A
J Immunol; 2011 Apr; 186(8):4994-5003. PubMed ID: 21411733
[TBL] [Abstract][Full Text] [Related]
4. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
5. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
Schiffer L; Bethunaickan R; Ramanujam M; Huang W; Schiffer M; Tao H; Madaio MP; Bottinger EP; Davidson A
J Immunol; 2008 Feb; 180(3):1938-47. PubMed ID: 18209092
[TBL] [Abstract][Full Text] [Related]
6. Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
Gardet A; Chou WC; Reynolds TL; Velez DB; Fu K; Czerkowicz JM; Bajko J; Ranger AM; Allaire N; Kerns HM; Ryan S; Legault HM; Dunstan RW; Lafyatis R; Lukashev M; Viney JL; Browning JL; Rabah D
PLoS One; 2016; 11(10):e0164423. PubMed ID: 27760209
[TBL] [Abstract][Full Text] [Related]
7. CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.
Bignon A; Gaudin F; Hémon P; Tharinger H; Mayol K; Walzer T; Loetscher P; Peuchmaur M; Berrebi D; Balabanian K
J Immunol; 2014 Feb; 192(3):886-96. PubMed ID: 24367031
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.
Londoño Jimenez A; Mowrey WB; Putterman C; Buyon J; Goilav B; Broder A
Arthritis Rheumatol; 2018 Nov; 70(11):1801-1806. PubMed ID: 29851285
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological factors for tubulointerstitial injury in lupus nephritis.
Lan-Ting H; You-Ming C; Li-Xin W; Chen W; Xiao-Yan Z; Hong-Yan H
Clin Rheumatol; 2020 May; 39(5):1617-1626. PubMed ID: 31902029
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.
Clark MR; Trotter K; Chang A
Semin Nephrol; 2015 Sep; 35(5):455-64. PubMed ID: 26573548
[TBL] [Abstract][Full Text] [Related]
11. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
12. Renal-infiltrating CD11c
Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
[TBL] [Abstract][Full Text] [Related]
13. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
[TBL] [Abstract][Full Text] [Related]
14. Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFN
Katewa A; Wang Y; Hackney JA; Huang T; Suto E; Ramamoorthi N; Austin CD; Bremer M; Chen JZ; Crawford JJ; Currie KS; Blomgren P; DeVoss J; DiPaolo JA; Hau J; Johnson A; Lesch J; DeForge LE; Lin Z; Liimatta M; Lubach JW; McVay S; Modrusan Z; Nguyen A; Poon C; Wang J; Liu L; Lee WP; Wong H; Young WB; Townsend MJ; Reif K
JCI Insight; 2017 Apr; 2(7):e90111. PubMed ID: 28405610
[TBL] [Abstract][Full Text] [Related]
15. JAK3-STAT pathway blocking benefits in experimental lupus nephritis.
Ripoll È; de Ramon L; Draibe Bordignon J; Merino A; Bolaños N; Goma M; Cruzado JM; Grinyó JM; Torras J
Arthritis Res Ther; 2016 Jun; 18(1):134. PubMed ID: 27278657
[TBL] [Abstract][Full Text] [Related]
16. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
Ko K; Wang J; Perper S; Jiang Y; Yanez D; Kaverina N; Ai J; Liarski VM; Chang A; Peng Y; Lan L; Westmoreland S; Olson L; Giger ML; Chun Wang L; Clark MR
Arthritis Rheumatol; 2016 Nov; 68(11):2740-2751. PubMed ID: 27159593
[TBL] [Abstract][Full Text] [Related]
18. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
19. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
20. Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis.
Cao Y; Tang W; Tang W
BMC Immunol; 2019 Oct; 20(1):37. PubMed ID: 31638917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
